Study of ACE Reno, Pico Cell Matrix for kidney health
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests a new treatment called ACE Reno, Pico Cell Matrix to see if it can improve kidney function in people with chronic kidney disease (CKD) at various stages. It may be an option if you have early to moderate kidney issues (including after a transplant) and are already on standard therapies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have kidney disease (any stage from 1 to 5, not on dialysis).
- You may have early signs (microalbuminuria), more protein in your urine, or have had a kidney transplant with protein in urine.
- You can be on standard kidney medicines like ACE inhibitors, ARBs, SGLT2 inhibitors, or MRAs.
- You must not have had a kidney transplant within the last 12 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new approach to protect the heart and kidneys in people with both chronic kidney disease and heart or blood vessel problems. By optimising treatment, researchers hope to reduce the risk of further kidney or heart damage.
This trial tests a new treatment for people with heart failure and severely reduced kidney function. It aims to see if the treatment can help protect both the heart and kidneys.
This study tests different treatments for people with advanced kidney disease, including those on dialysis or with a kidney transplant. It aims to find better ways to manage the condition and improve outcomes.
This study tests a new medicine called HS-10390 to see if it can help people with chronic kidney disease. It might slow down the disease and protect your kidneys.
This study looks at how blood vessels work in people with high blood pressure, type 2 diabetes, or chronic kidney disease, and in healthy volunteers. It uses special signals to understand blood vessel health, which may help improve future care.
This trial tests an investigational drug called HRS-1780 in people with chronic kidney disease. It aims to see if the drug can help slow kidney decline and is safe to use.
Hear when a new Chronic kidney disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.